Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
305 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Palchak David Md
Pismo Beach, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Memorial Cancer Institute at Memorial Regional Hospital
Hollywood, Florida, United States
- Memorial Regional Hospital/joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center
Jupiter, Florida, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- John B Amos Cancer Center
Columbus, Georgia, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Kuakini Medical Center
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Pob Ii
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 30 Nov 2014
- Completion
- 1 Jul 2019
- Last update posted
- 21 Oct 2019
- Registered enrollment
- 144
- Registry id
- NCT00892177
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.